According to the results of assays obtained with the use of assay systems ORTHO ELISA and ABBOTT HCV EIA (USA), the detection rate of anti-HCV-C100-3 among primary blood donors in Moscow was 1.37% and was not different from that among HBsAg carriers (1.8%) and among donors with anti-HCV-C100-3 in the blood (1.6%) (p < 0.01).
